[Determination of simvastatin in human plasma using ultra-performance liquid chromatography-tandem mass spectrometry].
A rapid, sensitive and specific method has been developed for the determination of simvastatin in human plasma with ultra-performance liquid chromatography-tandem mass spectrometry. Simvastatin and the internal standard (lovastatin) were extracted from human plasma with diethyl ether-n-hexane-isopropanol (80: 20 : 3, v/v/v), then separated on a Waters ACQUITY UPLC BEH C18 column (50 mm x 2.1 mm, 1.7 microm) with isocratic elution at a flow rate of 0.25 mL/min. The mobile phase was composed of 85% acetonitrile and 15% water (containing 10 mmol/L ammonium acetate). Electrospray ionization (ESI) source was applied and operated in positive ion mode. Multiple reaction monitoring (MRM) mode with the transitions of m/z 419. 2 --> m/z 199.0 and m/z 405. 0 --> m/z 199.0 was used to quantify simvastatin and the internal standard, respectively. The linear calibration curve was obtained in the concentration range of 0.051 - 20.4 ng/mL. The lower limit of quantification was 0.051 ng/mL. The inter-day and intra-day precision (relative standard deviation) were less than 10%, and the accuracy (relative error) was within -2.7% - 0% calculated from quality control samples. The mean extraction recovery of simvastatin was 91.6%. The method was proved to be selective, sensitive, rapid and suitable for the pharmacokinetic study of simvastatin.
Wang
Dong
D
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China. dickwang2008@163.com
Qin
Feng
F
Chen
Lingyun
L
Hao
Yu
Y
Zhang
Yi
Y
Li
Famei
F
D000284:Administration, Oral; D001774:Blood Chemical Analysis / Q000379:methods*; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D006801:Humans; D057230:Limit of Detection; D015203:Reproducibility of Results; D019821:Simvastatin / Q000008:administration & dosage / Q000097:blood* / Q000493:pharmacokinetics; D053719:Tandem Mass Spectrometry / Q000379:methods*
D019821:Simvastatin